Related Experiment Video
Updated: May 1, 2026

14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
15.6K
Normalized group activations based feature extraction technique using heterogeneous data for Alzheimer's disease
Krishnakumar Vaithianathan1, Julian Benadit Pernabas2, Latha Parthiban3
1Department of Computer Engineering, Karaikal Polytechnic College, Varichikudy, Karaikal, Puducherry, India.
Peerj. Computer Science
|December 9, 2024
Summary
A novel deep learning method using normalized group activations improves Alzheimer's disease (AD) diagnosis. This technique enhances classification accuracy for various AD stages using MRI and rs-fMRI data.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Medical Diagnostics
Background:
- Deep learning networks are crucial for identifying Alzheimer's disease (AD) patterns in neuroimaging.
- While individual activation functions are studied, group activations in neuroimaging lack comprehensive exploration.
- Existing methods may not fully capture complex atrophic patterns in AD.
Purpose of the Study:
- To propose a novel feature extraction technique using normalized group activations for Alzheimer's disease detection.
- To develop an automated diagnosis system applicable to both structural MRI and resting-state fMRI (rs-fMRI).
- To evaluate the system's performance across multiple AD stages and heterogeneous imaging features.
Main Methods:
- A two-phase approach: multi-trait condensed feature extraction and regional association networks.
- Utilizing multi-layered convolutional networks for feature extraction from brain regions.
- Training regional association networks with normalized group activations and feeding outputs to a classifier.
- Testing on diverse features (curvelets, wavelets, textures, etc.) and multi-cohort ADNI data.
Main Results:
- The proposed system demonstrated effective classification of multiple Alzheimer's disease stages.
- Achieved a 1-4% performance increase in mild cognitive impairment (MCI) classifications.
- Showcased discriminatory power and efficiency on both rs-fMRI time-series and MRI data.
Conclusions:
- The normalized group activation feature extraction method is effective for AD diagnosis.
- The automated system shows promise for classifying various stages of Alzheimer's disease using neuroimaging data.
- This technique offers a valuable tool for advancing neuroimaging analysis in AD research.
Related Concept Videos
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21

